Clinical Trial Update: A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 [Phase 2]

View source ↗

Summary

A Phase 2 feasibility study evaluated oral adjuvant chemotherapy with S-1 for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tomoshi Tsuchiya | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED